Applied and Environmental Microbiology, September 1999, p. 4134-4140, Vol. 65, No. 9
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Department of Biotechnology,
Received 24 March 1999/Accepted 7 July 1999
An expression system designed for cell surface display of hybrid
proteins on Staphylococcus carnosus has been evaluated for the display of Staphylococcus aureus protein A (SpA)
domains, normally binding to immunoglobulin G (IgG) Fc but here
engineered by combinatorial protein chemistry to yield SpA domains,
denoted affibodies, with new binding specificities. Such affibodies,
with human IgA or IgE binding activity, have previously been selected from a phage library, based on an SpA domain. In this study, these affibodies have been genetically introduced in monomeric or dimeric forms into chimeric proteins expressed on the surface of S. carnosus by using translocation signals from a
Staphylococcus hyicus lipase construct together with
surface-anchoring regions of SpA. The recombinant surface proteins,
containing the IgA- or IgE-specific affibodies, were demonstrated to be
expressed as full-length proteins, localized and properly exposed at
the cell surface of S. carnosus. Furthermore, these
chimeric receptors were found to be functional, since recombinant
S. carnosus cells were shown to have gained IgA and IgE
binding capacity, respectively. In addition, a positive effect in terms
of IgA and IgE reactivity was observed when dimeric versions of the
affibodies were present. Potential applications for recombinant
bacteria with redirected binding specificity in their surface proteins
are discussed.
The display of heterologous proteins
on the outer surface of bacteria has become an emerging topic in
different fields of research within applied bacteriology,
biotechnology, and vaccinology (7, 12, 45). The most-common
application has aimed toward the development of live bacterial vaccine
delivery systems by the exposure of foreign antigenic determinants at
the outer cell surface of gram-negative or gram-positive bacteria.
Escherichia coli and various Salmonella spp. have
dominated among the gram-negative bacteria (12, 45), but
various types of gram-positive bacteria have also been investigated,
including attenuated mycobacteria (46), commensal
streptococci (6, 37), and nonpathogenic food-grade
lactococcal (35) and staphylococcal (22, 41, 45)
species as well as sporulating Bacillus subtilis
(1). Bacterial surface display has also been employed for
surface expression of heterologous enzymes (9, 10, 47) and
for the development of novel microbial biocatalysts. Polyhistidyl
peptides have been surface exposed for capture of heavy metals,
potentially with environmental applications (43).
Single-chain scFv antibody fragments (i.e., the variable parts of the
heavy and light chains genetically linked together into a single chain)
have also been expressed in a surface-anchored functional form on both
gram-negative (8, 11) and gram-positive (18)
bacteria, and the potential use of such bacteria as whole-cell
diagnostic devices has been discussed previously (18, 45).
The gram-positive surface display systems have been reported to exhibit
some advantages compared to gram-negative bacteria, since translocation
through only one membrane is required and the gram-positive systems
seem to allow surface display of larger proteins. Moreover, the
gram-positive bacteria are considered to be more rigid, due to the
thick cell wall surrounding the cells (7, 45). Such bacteria
would be less likely to lyse through shear forces and would thus be
more suitable in applications based on whole-cell reagents.
Two staphylococcal candidates which are being investigated extensively
for various surface display applications are the nonpathogenic Staphylococcus xylosus and Staphylococcus
carnosus (2, 22, 27, 28, 30, 31, 39), both of which
traditionally have been used as starter cultures in meat fermentation
applications (20, 26). Of the two staphylococcal species,
the system based on the use of S. carnosus has been
demonstrated to result generally in a more efficient display of
heterologous surface proteins (39), on the order of
104 per bacterial cell (2). With S. carnosus as a host, the signal sequence and propeptide of a
Staphylococcus hyicus lipase gene construct (13)
have been used together with the staphylococcal protein A (SpA) cell
surface-anchoring sequences (42) to achieve translocation
and proper surface exposure.
In a previous study, we were able to demonstrate the expression of a
murine anti-human-immunoglobulin E (IgE) scFv antibody fragment as
surface exposed on S. xylosus and S. carnosus
(18), and we could show that the recombinant bacteria,
particularly S. carnosus, were capable of reacting in
whole-cell assays to the antigen human IgE. Here we evaluated the
possibility of exposing on the surface of S. carnosus
tailor-made binding molecules, created by combinatorial protein
engineering of an SpA domain, Z (32), which normally binds
to IgG Fc (fragment crystallizable). An attempt to obtain such novel
binding proteins with completely new specificities was recently
initiated by using phage display in vitro selection technology. By
using genetic engineering, libraries of the Z domain were created in
which 13 surface residues (involved in the IgG Fc binding) of the
domain were randomly and simultaneously substituted (34).
This Z library was genetically fused to the coat protein III of
filamentous phage M13, resulting in a phage library adapted for
selection of novel specificities by biopanning (33). Novel Z
variants, or "affibodies" (21, 33), have successfully
been selected to diverse targets, such as Taq DNA
polymerase, human insulin, a human apolipoprotein variant, and the G
protein of human respiratory syncytial virus (21, 33).
Recently, and analogous to the achievements of Nord and coworkers
(33), such affibody ligands were selected against human IgA
(38) and IgE (17), respectively.
Our overall objective in this study was to determine whether the IgA-
and IgE-reactive affibodies could be expressed in an active form as
parts of chimeric surface proteins on S. carnosus, thus
creating a staphylococcal bacterium which has gained binding activity
to human IgA or IgE, respectively. Gene fragments encoding either
monomeric or dimeric forms of the affibodies were introduced into gene
constructs encoding the chimeric surface proteins to evaluate the
effects of ligand dimerization on IgA and IgE reactivity. The potential
use of such recombinant staphylococci as whole-cell diagnostic devices
or biosorbents or as alternatives to filamentous phages for the surface
display of affibody libraries for selection is discussed.
Strains and vectors.
The strains and plasmids used in this
study are listed in Table 1.
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Strains and plasmids
Preparation and transformation of protoplasts. The preparation and transformation of protoplasts were performed as described by Götz and collaborators (14, 15).
Antibodies.
Purified, myeloma-derived human IgA and IgE were
obtained from Pharmacia and Upjohn Diagnostics (Uppsala, Sweden).
Secondary antibodies used in this study were affinity-purified
polyclonal rabbit anti-human IgA and three different mouse monoclonal
IgG antibodies reactive with constant domains (C
2,
C
3, or C
4) of human IgE, all conjugated
with a
-galactosidase enzyme (Pharmacia and Upjohn Diagnostics).
Selection of IgA- and IgE-reactive affibodies.
Affibodies to
human IgA and human IgE, respectively, were selected by using the phage
libraries Zlib-1 and Zlib-2, essentially as described by Nord and
coworkers (33). Briefly, polyethylene glycol-precipitated
phage stocks of libraries Zlib-1 and Zlib-2 were incubated with
streptavidin-coated paramagnetic beads (M-280; Dynal AS, Oslo, Norway)
with immobilized biotinylated target molecules, IgA, or a chimeric IgE
(Pharmacia and Upjohn Diagnostics). After several washing steps, bound
phages were eluted with low pH and used for reinfection of log-phase
E. coli RRI
M15 cells (40). The procedure was
repeated, and potential binders were sequenced. The selected affibodies
had the following amino acid substitutions relative to the original
sequence of domain Z (33) at the randomized positions: Q9T,
Q10I, N11Q, F13S, Y14Q, L17R, H18L, E24G, E25R, R27K, N28L, Q32H, and
K35L for the IgA-specific affibody and Q9P, Q10T, N11A, F13S, Y14L,
L17M, H18M, E24V, E25D, R27V, N28G, Q32G, and K35M for the IgE-specific
affibody. A detailed description of the phage display-based panning
procedures to obtain the two affibodies ZIgA and
ZIgE as well as a detailed evaluation of their binding
characteristics by real-time biospecific interaction analysis (BIA)
with a model 2000 instrument (Biacore AB, Uppsala, Sweden) will be
published elsewhere (17, 38). Separate injections of
ZIgA and ZIgE proteins over sensor chip
surfaces coated with human IgA, IgE, IgG showed that the selected
affibodies bound only their respective targets and thus showed no
detectable cross-reactivity (data not shown). The dissociation
constants (Kd) for the monomeric ZIgA and ZIgE affibodies to their respective
targets, as determined by BIA, were found to be 0.5 and 0.4 µM,
respectively (17, 38).
DNA constructions. Gene fragments encoding either monomeric or dimeric variants of the two affibodies, ZIgA and ZIgE could be amplified by PCR by using primers SAPA-27 (5'-GGGGGATCCTGTAGACAACAAATTCAACAAAG-3') and SAPA-28 (5'-GGGGTCGACTTCGGCGCCTGAGCATC-3') and with pKN1 phagemids (34), carrying inserts corresponding to dimeric versions of the two affibodies, as templates. Generated gene fragments were restricted with endonucleases SalI and BamHI and ligated to plasmid pSPPmABPXM (41), restricted by using the same enzymes. Solid-phase DNA sequencing (23) was performed by employing the indocarbocyanine dye ALFred (Cy5) phosphoramidite-labeled sequencing primers SAPA-25 (5'-TTACATCACAAGCGAGCGAC-3') and SAPA-26 (5'-TGCTTTGGCTTTTGCTAGAG-3') on a robotic workstation (Biomek 1000; Beckman Instruments, Fullerton, Calif.), and the obtained Sanger fragments were analyzed on an ALFexpress (Amersham Pharmacia Biotech, Uppsala, Sweden). The four verified expression vectors pSPPmZIgAABPXM, pSPPdZIgAABPXM, pSPPmZIgEABPXM, and pSPPdZIgEABPXM, designed for surface expression on S. carnosus, encode the surface-anchored fusion proteins PP-ZIgA-ABP-XM', PP-ZIgA-ZIgA-ABP-XM', PP-ZIgE-ABP-XM', and PP-ZIgE-ZIgE-ABP-XM', respectively. The expression vectors were used to transform S. carnosus protoplasts so as to generate the four recombinant S. carnosus strains, which for simplicity were denoted Sc:mZIgA, Sc:dZIgA, Sc:mZIgE, and Sc:dZIgE. The m and d annotations indicate either monomeric or dimeric versions of the affibodies.
Extraction and purification of the chimeric surface
proteins.
Extraction of the chimeric proteins from the cell wall
of the recombinant S. carnosus was performed essentially as
previously described (41). Briefly, cells harboring the
parental vector pSSPmABPXM, denoted Sc:ABP, or the four new recombinant
staphylococcal strains Sc:mZIgA, Sc:dZIgA,
Sc:mZIgE, and Sc:dZIgE were grown at 37°C in
50 ml of tryptone soy broth medium (TSB; Difco), supplemented with
yeast extract (5 g/liter; Difco) and chloramphenicol (10 mg/liter)
until the optical density at 578 nm (OD578) reached
1.
Cells were washed twice in phosphate-buffered saline with 0.05% Tween
20 (PBST) and subjected to a cell wall-degrading treatment by using
lysostaphin (Sigma). The cell pellets were dissolved in 6 ml of SMM
solution (1 M sucrose, 40 mM maleic acid, and 40 mM MgCl2
[pH 6.5]), and 18 U of lysostaphin was added before incubation at
37°C for 1.5 h. The formed protoplasts were pelleted at
6,000 × g for 15 min, and the supernatants were
diluted 10 times in Tris-buffered saline containing Tween (TST; 25 mM
Trizma base-HCl [pH 8], 0.2 M NaCl, 1 mM EDTA, 0.05% Tween 20) and
loaded onto a human serum albumin (HSA)-Sepharose column
(36) for affinity purification. Eluted fractions were pooled
and lyophilized prior to a sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) (4 to 20% polyacrylamide) analysis (Novex,
San Diego, Calif.) under reducing conditions.
Enzymatic assay for detection of cell surface-exposed chimeric
proteins.
Wild-type S. carnosus cells and the
recombinant staphylococci Sc:ABP, Sc:mZIgA,
Sc:dZIgA, Sc:mZIgE, and Sc:dZIgE
were grown overnight and diluted 1:200 in TSB medium supplemented with
yeast extract (and chloramphenicol for the recombinant cells) and
further grown at 37°C until the OD578 reached
1. The
cells were harvested and washed twice in PBST. One milliliter of cell
suspension, diluted in PBST to an OD578 of
1, was
incubated with biotinylated HSA (biotinylated with
D-biotinoyl-
-aminocaproic acid
N-hydroxysuccinimide ester [Boehringer] according to the
supplier's recommendations) at a final concentration of 62 nM for 30 min at room temperature. After the cells were washed three times in
PBST, they were resuspended in 1 ml of PBST containing 0.5 U of
streptavidin-alkaline phosphatase (Boehringer) and incubated for 30 min
at room temperature. The mixtures were washed twice in PBST and once in
substrate buffer (1 M diethanolamine-HCl [pH 9.8], 0.5 mM
MgCl2) before the different cell types were resuspended in
5 ml of substrate buffer. Six 100-µl aliquots of each cell type were
loaded in a microtiter plate before the addition of 100 µl of the
substrate solution, p-nitrophenylphosphate (Sigma). The
change in A405 was measured after 10 min in an
enzyme-linked immunosorbent assay (ELISA) reader (SLT EAR 340AT;
SLT-Labinstruments, Grödig, Austria).
Colorimetric assay to analyze the functionality of
surface-displayed Ig binding surface proteins.
The different
recombinant S. carnosus bacteria were grown and washed as
described above, and 0.5 ml of cells corresponding to an
OD578 of
1 were incubated with 2 µg of human IgA or
human IgE for 45 min at room temperature. The samples were washed twice in PBST and incubated for 45 min at room temperature in 0.5 ml of PBST
supplemented with
-galactosidase-conjugated polyclonal rabbit
anti-IgA antibodies diluted 1:150 or a mixture of 1.5 µg of each of
three different
-galactosidase-conjugated murine anti-IgE monoclonal
antibodies (Pharmacia and Upjohn Diagnostics). The bacteria were washed
twice in PBST and once in substrate buffer (0.2 M Na-phosphate buffer
[pH 7.4], 2 mM MgCl2, 8% methanol, 0.25% Tween 20)
before they were resuspended in 2.5 ml of substrate buffer. Six
100-µl aliquots were loaded in ELISA plate wells for each different
cell type before the addition of 100 µl of the substrate
o-nitrophenyl-
-D-galactopyranoside (ONPG)
(9.2 mM in substrate buffer; Sigma). The change in
A405 was determined after 60 min in an ELISA
reader. As negative controls, similar experiments were performed, but
the specific target protein human IgA or IgE was left out.
| |
RESULTS |
|---|
|
|
|---|
Background. In this study, we investigated the possibility of displaying engineered SpA domains with novel binding specificities on the surface of S. carnosus in order to create recombinant staphylococci having binding capacities for IgA or IgE. Two such engineered SpA domains, termed affibodies, have been selected by phage display technology from protein libraries constructed by combinatorial strategies (17, 38) by using the 58-amino-acid Z domain (32) as a protein scaffold, analogous to work described by Nord and coworkers (33, 34). The two new SpA domains were successfully selected by biopanning by using human IgA and IgE antibodies, respectively, as target proteins. A detailed description of the panning procedures used to obtain the two affibodies ZIgA and ZIgE as well as a detailed evaluation of their binding characteristics by real-time biospecific interaction analysis will be published elsewhere (17, 38).
Expression vectors for surface display on S. carnosus. Four novel E. coli-staphylococcus shuttle vectors were constructed, designed for surface display of chimeric proteins containing the new ZIgA and ZIgE affibodies, on S. carnosus. The parental vector (41) as well as the four constructed expression vectors together with the encoded gene products PP-ABP-XM', PP-ZIgA-ABP-XM', PP-ZIgA-ZIgA-ABP-XM', PP-ZIgE-ABP-XM', and PP-ZIgE-ZIgE-ABP-XM' are depicted in Fig. 1. M' represents the processed and covalently anchored form (29, 42) of the M sequence of SpA. For simplicity, the five recombinant S. carnosus strains were denoted Sc:mZIgA, Sc:dZIgA, Sc:mZIgE, Sc:dZIgE, and Sc:ABP. The S. carnosus expression vectors utilize the promoter, signal sequence, and propeptide sequence (PP) from an S. hyicus lipase gene construct, optimized for expression in S. carnosus (25). The vector system also contains gene fragments from the SpA gene (48) as follows: X, encoding a charged repetitive region postulated to interact with the peptidoglycan cell wall (19), and M, encoding a region common in gram-positive cell surface-bound receptors that is required for cell surface anchoring (29, 42). In addition, the gene encoding an albumin binding protein (ABP), derived from streptococcal protein G (36, 41), is also present in the expression vectors. The ABP region is expressed as the part of the chimeric surface proteins closest to the cell wall-anchoring motifs (41). It has been demonstrated to be useful as a reporter peptide in a colorimetric assay to analyze surface accessibility of the hybrid surface proteins (18, 39, 41) and as an affinity tag for recovery of the expressed recombinant surface proteins (18, 41) and has also been shown to act as a spacer protein to increase surface accessibility (44). Note that the PP from the S. hyicus lipase is not processed in S. carnosus (13), while it is processed in its homologous host, S. hyicus (3). This propeptide has been described as essential for the secretion of heterologous gene fusion products from S. carnosus (5) when the lipase signal peptide is used for secretion.
|
Extraction, affinity purification, and characterization of the chimeric surface proteins. To investigate the expression of the different chimeric surface proteins, the recombinant staphylococci Sc:mZIgA, Sc:dZIgA, Sc:mZIgE, and Sc:dZIgE (Fig. 1) and S. carnosus cells harboring the parental vector pSPPmABPXM (Sc:ABP was included as a reference) were cultivated to equal cell densities, harvested, and subjected to lysostaphin treatment to release cell wall-bound proteins. After centrifugation, the protein-containing supernatants were loaded onto HSA columns for ABP-mediated affinity purification of the recombinant surface proteins. Eluted proteins were analyzed by SDS-PAGE (Fig. 2). Extracted and affinity-purified material from cultures of Sc:ABP (lane 1) and Sc:mZIgA (lane 2), Sc:dZIgA (lane 3), Sc:mZIgE (lane 4), and Sc:dZIgE (lane 5) all showed major protein bands of essentially the expected sizes (65, 71, 78, 71, and 77 kDa, respectively). In accordance with earlier observations for proteins containing the lipase propeptide (13, 41), the recovered chimeric proteins migrated as slightly larger proteins. Furthermore, the purified chimeric proteins showed little or no proteolytic degradation (Fig. 2). The high stability to proteolytic degradation is perhaps not that surprising, considering that the ZIgA and ZIgE affibody domains are of staphylococcal origin, but it is of significant interest, since alternative protein domains, such as scFv antibody fragments, have been shown to be more susceptible to proteolysis when they are expressed as surface anchored in staphylococci (18). This assay thus indicates that the chimeric surface proteins were expressed as full-length gene products, which were correctly targeted to the cell wall of S. carnosus.
|
Investigation of the surface accessibility and the Ig binding functions. The surface accessibility of the expressed chimeric surface proteins was investigated by a colorimetric enzymatic assay (41), taking advantage of the albumin binding reporter moiety, ABP, present within the recombinant proteins. For wild-type and recombinant staphylococci Sc:ABP, Sc:mZIgA, Sc:dZIgA, Sc:mZIgE, and Sc:dZIgE (Fig. 1), which were incubated with biotinylated HSA and a streptavidin-alkaline phosphatase conjugate, the presence of ABP-containing surface receptors was detected by using a chromogenic substrate. ABP was detectable on all the recombinant staphylococci (Fig. 3, bars 2 to 6), whereas wild-type S. carnosus cells, as expected, showed no albumin binding capacity (Fig. 3, bar 1). This demonstrates that the chimeric surface proteins with the capacity of binding to serum albumin were successfully targeted and anchored, in accessible forms, to the outer surface of the recombinant staphylococci. Interestingly, the levels of surface expression of chimeric proteins containing affibody domains (Fig. 3, bars 3 to 6), seemed to be of the same magnitude as those for the fusion protein construct encoded by the parental vector (Fig. 3, bar 2), suggesting that the surface density of chimeric proteins was not reduced by the introduction of monomeric and dimeric affibody domains. This contrasts with earlier results, in which the levels of surface expression of recombinant proteins appeared to be reduced when peptides and protein domains of various origins were introduced genetically into the surface proteins (18, 28, 39), and might be explained by the staphylococcal origin of the SpA-derived affibodies.
|
-galactosidase-conjugated polyclonal anti-IgA reagent or a mixture of three different murine
-galactosidase-conjugated IgE-specific monoclonal antibodies. When
the staphylococcal cells expressing monomeric or dimeric
ZIgA affibody domains were analyzed for their IgA binding
capacity, a significant response was detected (Fig.
4, bars 2 and 3, shaded) compared to that
in the cells harboring the parental vector (Fig. 4, bar 1, shaded), and
a similar low background binding was observed for all constructs when
IgA was omitted (Fig. 4, bars 1 to 3, white). When recombinant
staphylococci carrying monomeric or dimeric ZIgE affibody
variants were analyzed by a similar assay for their binding to IgE, a
significant IgE reactivity was observed (Fig. 4, bars 5 and 6, shaded)
compared to that for the control cells expressing the PP-ABP-XM'
protein (Fig. 4, bar 4, shaded). In this case, the negative control
experiments, i.e., those with IgE omitted, resulted in a slightly
higher background response (Fig. 4, bars 5 and 6, white), which was,
however, of a magnitude similar to that of control cells (Fig. 4, bar
4, white).
|
| |
DISCUSSION |
|---|
|
|
|---|
We have described how SpA domains, selected from phage-displayed combinatorial libraries, with binding specificity for human IgA and IgE, respectively, have been expressed as part of chimeric surface proteins in S. carnosus, thus generating staphylococcal cells capable of binding IgA and IgE, respectively. The different chimeric proteins were shown to be localized to the staphylococcal cell walls, from which they could be extracted and purified by affinity chromatography, by using an albumin-binding protein region, ABP, present in the chimeric surface proteins. The recovered surface proteins were shown to be proteolytically stable. In a previous study, it was demonstrated that S. carnosus cells transformed with the parental vector pSPPmABPXM carried approximately 104 surface-exposed chimeric proteins per cell (2). Since the recombinant staphylococci presented here, Sc:mZIgA, Sc:dZIgA, Sc:mZIgE, and Sc:dZIgE (Fig. 1), seem to express surface proteins at a level similar to that of the control cells (Fig. 3), it is likely that the numbers of surface proteins displayed by these recombinant staphylococci are in the same order of magnitude.
In an earlier study aimed to generate staphylococcal cells with IgE binding capacity, an anti-IgE scFv antibody construct was introduced into the S. carnosus surface expression system (18). In that study, a marked proteolytic degradation as well as a decreased surface expression of the chimeric surface proteins was observed (18). The staphylococcal origin of the SpA-derived affibodies used in this study might partially explain the improved expression and display characteristics observed.
Various applications of the strategy employed to create staphylococcal cells carrying protein A derivatives with redirected binding specificities can be envisioned. One practical application for this type of recombinant bacteria would be to use them as whole-cell monoclonal antibodies in different diagnostic tests. The described strategy could prove to be a straightforward and cost-effective way of producing monoclonal antibodies for diagnostic purposes. The resulting recombinant bacteria might also be suitable for immunoprecipitation experiments or, in an immobilized form (24), as inexpensive adsorbents for the recovery of IgE or IgA.
A second application for the described strategy would be to improve bacterial vaccine delivery systems by the selection and display of protein domains which would target the bacterial vaccine delivery vehicle to immunoreactive sites. Recombinant S. carnosus cells have been extensively investigated in the context of vaccine delivery (44), and attempts to improve immunogenicity include the surface display of the cholera toxin B subunit (CTB) (4, 28) or various fibronectin binding domains (27). The creation of purposely designed targeting domains would potentially improve such vaccine delivery systems.
Irrespective of the application, it is of the utmost importance to construct bacteria that bind efficiently to a desired target molecule. One way of improving the binding capacity has been demonstrated in the present study by dimerization of the affibody. However, it cannot be concluded from our results whether the obtained improved binding is due to sterical effects or an increased apparent affinity via avidity effects. Analogous to other affibodies selected from the naive Z domain libraries (21, 33), the affibodies used in this study have affinities (Kd) to their targets in the micromolar range. Gunneriusson and coworkers have shown that affibodies of significantly higher affinities can be isolated by using an affinity maturation strategy (16). Such affibodies might be useful for the creation of potent whole-cell diagnostic devices or efficient vaccine delivery vehicles.
Furthermore, it would be of obvious interest to investigate whether recombinant staphylococci could be used directly as an alternative to filamentous phages for the display of affibody libraries to achieve subsequent affinity selection of relevant affibodies by using fluorescence-activated cell sorting technology. This would thus circumvent the phage display selection procedure used in this study for the initial selection of the ZIgA and ZIgE affibodies.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to M. Uhlén and K. Nord for valuable discussions.
This work was financially supported by The Swedish National Board for Technical and Industrial Development (NUTEK).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biotechnology, Royal Institute of Technology (KTH), S-100 44 Stockholm, Sweden. Phone: 46 8 790 6497. Fax: 46 8 245452. E-mail: stefans{at}biochem.kth.se.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Acheson, D. W. K., A. L. Sonenshein, J. M. Leong, and G. T. Keusch. 1997. Heat-stable spore-based vaccines: surface expression of invasin-cell wall fusion proteins in Bacillus subtilis, p. 179-184. In F. Brown, D. Burton, P. Doherty, J. Mekalanos, and E. Norrby (ed.), Vaccines 97. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 2. | Andréoni, C., L. Goetsch, C. Libon, P. Samuelson, T. N. Nguyen, A. Robert, M. Uhlén, H. Binz, and S. Ståhl. 1997. Flow cytometric quantification of surface-displayed recombinant receptors on staphylococci. BioTechniques 23:696-704. [Medline] |
| 3. |
Ayora, S.,
P. E. Lindgren, and F. Götz.
1994.
Biochemical properties of a novel metalloprotease from Staphylococcus hyicus subsp. hyicus involved in extracellular lipase processing.
J. Bacteriol.
176:3218-3223 |
| 4. | Cano, F., S. Liljeqvist, T. N. Nguyen, P. Samuelson, J.-Y. Bonnefoy, S. Ståhl, and A. Robert. A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery. FEMS Immunol. Med. Microbiol., in press. |
| 5. | Demleitner, G., and F. Götz. 1994. Evidence for importance of the Staphylococcus hyicus lipase pro-peptide in lipase secretion, stability and activity. FEMS Microbiol. Lett. 121:189-197[Medline]. |
| 6. | Di Fabio, S., D. Medaglini, C. M. Rush, F. Corrias, G. L. Panzini, M. Pace, P. Verani, G. Pozzi, and F. Titti. 1998. Vaginal immunization of cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens. Vaccine 16:485-492[Medline]. |
| 7. | Fischetti, V. A., D. Medaglini, and G. Pozzi. 1996. Gram-positive commensal bacteria for mucosal vaccine delivery. Curr. Opin. Biotechnol. 7:659-666[Medline]. |
| 8. |
Francisco, J. A.,
R. Campbell,
B. L. Iverson, and G. Georgiou.
1993.
Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface.
Proc. Natl. Acad. Sci. USA
90:10444-10448 |
| 9. |
Francisco, J. A.,
C. F. Earhart, and G. Georgiou.
1992.
Transport and anchoring of -lactamase to the external surface of Escherichia coli.
Proc. Natl. Acad. Sci. USA
89:2713-2717 |
| 10. | Francisco, J. A., C. Stathopoulos, R. A. Warren, D. G. Kilburn, and G. Georgiou. 1993. Specific adhesion and hydrolysis of cellulose by intact Escherichia coli expressing surface anchored cellulase or cellulose binding domains. Bio/Technology 11:491-495[Medline]. |
| 11. | Fuchs, P., F. Breitling, S. Dubel, T. Seehaus, and M. Little. 1991. Targeting recombinant antibodies to the surface of Escherichia coli: fusion to a peptidoglycan associated lipoprotein. Bio/Technology 9:1369-1372[Medline]. |
| 12. | Georgiou, G., C. Stathopoulos, P. S. Daugherty, A. R. Nayak, B. L. Iverson, and R. I. Curtiss. 1997. Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines. Nat. Biotechnol. 15:29-34. [Medline] |
| 13. | Götz, F. 1990. Staphylococcus carnosus: a new host organism for gene cloning and protein production. J. Appl. Bacteriol. Symp. Suppl. 19:49S-53S. |
| 14. |
Götz, F.,
S. Ahrne, and M. Lindberg.
1981.
Plasmid transfer and genetic recombination by protoplast fusion in staphylococci.
J. Bacteriol.
145:74-81 |
| 15. | Götz, F., and B. Schumacher. 1987. Improvements of protoplast transformation in Staphylococcus carnosus. FEMS Microbiol. Lett. 40:285-288. |
| 16. | Gunneriusson, E., K. Nord, M. Uhlén, and P.-Å. Nygren. Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling. Protein Eng., in press. |
| 17. | Gunneriusson, E., J. Ringdahl, M. Högbom, H. Grönlund, and P.-Å. Nygren. Unpublished data. |
| 18. |
Gunneriusson, E.,
P. Samuelson,
M. Uhlén,
P.-Å. Nygren, and S. Ståhl.
1996.
Surface display of a functional single-chain Fv antibody on staphylococci.
J. Bacteriol.
178:1341-1346 |
| 19. | Guss, B., M. Uhlén, B. Nilsson, M. Lindberg, J. Sjöquist, and J. Sjödahl. 1984. Region X, the cell-wall-attachment part of staphylococcal protein A. Eur. J. Biochem. 138:413-420[Medline]. |
| 20. | Hammes, W. P., I. Bosch, and G. Wolf. 1995. Contribution of Staphylococcus carnosus and Staphylococcus piscifermentans to the fermentation of protein foods. J. Appl. Bacteriol. Symp. Suppl. 79:76S-83S. |
| 21. | Hansson, M., J. Ringdahl, A. Robert, U. Power, L. Goetsch, T. N. Nguyen, M. Uhlén, S. Ståhl, and P.-Å. Nygren. 1999. An in vitro selected binding protein (affibody) shows conformation-independent recognition of the respiratory syncytial virus (RSV) G protein. Immunotechnology 4:237-252. [Medline] |
| 22. |
Hansson, M.,
S. Ståhl,
T. N. Nguyen,
T. Bachi,
A. Robert,
H. Binz,
A. Sjölander, and M. Uhlén.
1992.
Expression of recombinant proteins on the surface of the coagulase-negative bacterium Staphylococcus xylosus.
J. Bacteriol.
174:4239-4245 |
| 23. |
Hultman, T.,
S. Ståhl,
E. Hornes, and M. Uhlén.
1989.
Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support.
Nucleic Acids Res.
17:4937-4946 |
| 24. | Kessler, S. W. 1981. Use of protein A-bearing staphylococci for the immunoprecipitation and isolation of antigens from cells. Methods Enzymol. 73:442-459[Medline]. |
| 25. | Liebl, W., and F. Götz. 1986. Studies on lipase directed export of Escherichia coli beta-lactamase in Staphylococcus carnosus. Mol. Gen. Genet. 204:166-173[Medline]. |
| 26. | Liepe, H.-U. 1982. Bakterienkulturen und Rohwurst. Forum Mikrobiologie 5:10-15. |
| 27. | Liljeqvist, S., F. Cano, T. N. Nguyen, M. Uhlén, A. Robert, and S. Ståhl. 1999. Surface display of functional fibronectin-binding domains on Staphylococcus carnosus. FEBS Lett. 446:299-304[Medline]. |
| 28. | Liljeqvist, S., P. Samuelson, M. Hansson, T. N. Nguyen, H. Binz, and S. Ståhl. 1997. Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus. Appl. Environ. Microbiol. 63:2481-2488[Abstract]. |
| 29. | Navarre, W. W., and O. Schneewind. 1994. Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in gram-positive bacteria. Mol. Microbiol. 14:115-121[Medline]. |
| 30. | Nguyen, T. N., M. H. Gourdon, M. Hansson, A. Robert, P. Samuelson, C. Libon, C. Andréoni, P.-Å. Nygren, H. Binz, M. Uhlén, and S. Ståhl. 1995. Hydrophobicity engineering to facilitate surface display of heterologous gene products on Staphylococcus xylosus. J. Biotechnol. 42:207-219[Medline]. |
| 31. | Nguyen, T. N., M. Hansson, S. Ståhl, T. Bächi, A. Robert, W. Domzig, H. Binz, and M. Uhlén. 1993. Cell-surface display of heterologous epitopes on Staphylococcus xylosus as a potential delivery system for oral vaccination. Gene 128:89-94[Medline]. |
| 32. |
Nilsson, B.,
T. Moks,
B. Jansson,
L. Abrahmsén,
A. Elmblad,
E. Holmgren,
C. Henrichson,
T. A. Jones, and M. Uhlén.
1987.
A synthetic IgG-binding domain based on staphylococcal protein A.
Protein Eng.
1:107-113 |
| 33. |
Nord, K.,
E. Gunneriusson,
J. Ringdahl,
S. Ståhl,
M. Uhlén, and P.-Å. Nygren.
1997.
Binding proteins selected from combinatorial libraries of an -helical bacterial receptor domain.
Nat. Biotechnol.
15:772-777.
[Medline] |
| 34. |
Nord, K.,
J. Nilsson,
B. Nilsson,
M. Uhlén, and P.-Å. Nygren.
1995.
A combinatorial library of an -helical bacterial receptor domain.
Protein Eng.
8:601-608 |
| 35. | Norton, P. M., H. W. Brown, J. M. Wells, A. M. Macpherson, P. W. Wilson, and R. W. Le Page. 1996. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis. FEMS Immunol. Med. Microbiol. 14:167-177[Medline]. |
| 36. | Nygren, P.-Å., M. Eliasson, E. Palmcrantz, L. Abrahmsén, and M. Uhlén. 1988. Analysis and use of the serum albumin binding domains of streptococcal protein G. J. Mol. Recognit. 1:69-74[Medline]. |
| 37. |
Pozzi, G.,
M. Contorni,
M. R. Oggioni,
R. Manganelli,
M. Tommasino,
F. Cavalieri, and V. A. Fischetti.
1992.
Delivery and expression of a heterologous antigen on the surface of streptococci.
Infect. Immun.
60:1902-1907 |
| 38. | Ringdahl, J., E. Gunneriusson, H. Grönlund, and P.-Å. Nygren. Unpublished data. |
| 39. | Robert, A., P. Samuelson, C. Andréoni, T. Bachi, M. Uhlén, H. Binz, T. N. Nguyen, and S. Ståhl. 1996. Surface display on staphylococci: a comparative study. FEBS Lett. 390:327-333[Medline]. |
| 40. |
Rüther, U.
1982.
pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts.
Nucleic Acids Res.
10:5765-5772 |
| 41. |
Samuelson, P.,
M. Hansson,
N. Ahlborg,
C. Andréoni,
F. Götz,
T. Bächi,
T. N. Nguyen,
H. Binz,
M. Uhlén, and S. Ståhl.
1995.
Cell surface display of recombinant proteins on Staphylococcus carnosus.
J. Bacteriol.
177:1470-1476 |
| 42. |
Schneewind, O.,
A. Fowler, and K. F. Faull.
1995.
Structure of the cell wall anchor of surface proteins in Staphylococcus aureus.
Science
268:103-106 |
| 43. | Sousa, C., A. Cebolla, and V. de Lorenzo. 1996. Enhanced metalloadsorption of bacterial cells displaying poly-His peptides. Nat. Biotechnol. 14:1017-1020. [Medline] |
| 44. | Ståhl, S., P. Samuelson, M. Hansson, C. Andréoni, L. Goetsch, C. Libon, S. Liljeqvist, E. Gunneriusson, H. Binz, T. N. Nguyen, and M. Uhlén. 1997. Development of non-pathogenic staphylococci as vaccine delivery vehicles, p. 62-81. In G. Pozzi, and J. M. Wells (ed.), Gram-positive bacteria: vaccine vehicles for mucosal immunization. Landes Bioscience, Georgetown, Tex. |
| 45. | Ståhl, S., and M. Uhlén. 1997. Bacterial surface display: trends and progress. Trends Biotechnol. 15:185-192[Medline]. |
| 46. |
Stover, C. K.,
G. P. Bansal,
M. S. Hanson,
J. E. Burlein,
S. R. Palaszynski,
J. F. Young,
S. Koenig,
D. B. Young,
A. Sadziene, and A. G. Barbour.
1993.
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
J. Exp. Med.
178:197-209 |
| 47. | Strauss, A., and F. Götz. 1996. In vivo immobilization of enzymatically active polypeptides on the cell surface of Staphylococcus carnosus. Mol. Microbiol. 21:491-500[Medline]. |
| 48. |
Uhlén, M.,
B. Guss,
B. Nilsson,
S. Gatenbeck,
L. Philipson, and M. Lindberg.
1984.
Complete sequence of the staphylococcal gene encoding protein A.
J. Biol. Chem.
259:1695-1702 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|